Morselized Amniotic and Umbilical Tissue Compositions for Wound Healing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing technologies lack effective compositions and methods for modulating cellular physiology and pathological processing using umbilical cord and amniotic membrane tissues, particularly in wound care and tissue regeneration.
Innovation Solution
Compositions of morselized amniotic membrane and umbilical cord tissues, which can be in liquid, semi-liquid, or lyophilized form, are developed to suppress TGF β signaling, increase apoptosis of macrophages, decrease cellular proliferation and migration, and protect cells from apoptosis and inflammation, with methods for preparation, storage, and application in therapeutic and cosmetic uses.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If morselized umbilical cord and amniotic membrane compositions are used, then wound healing and tissue regeneration are enhanced, but the complexity of preparation and standardization increases
Solution Approach 1:
The umbilical cord and amniotic membrane tissues are divided into small morselized particles (0.1-2.0 mm diameter) to increase surface area and enhance cellular interaction, while maintaining the beneficial bioactive components for wound healing and tissue regeneration
Solution Approach 2:
The tissue morphology is transformed from intact sheets to standardized morselized particles with controlled size parameters, and the physical state is changed through lyophilization to create stable, shelf-ready compositions that simplify storage and application
2Reliability
If fresh umbilical cord and amniotic membrane tissues are used, then cellular activity and regenerative potential are maximized, but storage stability and shelf life are reduced
Solution Approach 1:
The tissue composition undergoes phase transition through lyophilization (freeze-drying) from fresh hydrated state to a stable dry state, preserving bioactive components and cellular structures while enabling long-term storage at room temperature or refrigeration without compromising regenerative potential
Solution Approach 2:
The tissues are pre-processed through morselization and lyophilization before storage, preparing them in advance for stable shelf storage while maintaining cellular viability and regenerative activity when rehydrated and applied to wounds
3Manufacturing precision
If standardized morselized compositions are produced, then manufacturing consistency is improved, but the complexity of tissue processing increases
Solution Approach 1:
Tissues are systematically divided into uniform morselized particles using controlled mechanical or enzymatic processes, achieving consistent particle size distribution (0.1-2.0 mm) that ensures reproducible cellular interactions and therapeutic outcomes
Solution Approach 2:
The composition combines morselized umbilical cord tissue and amniotic membrane tissue in defined ratios within a sterile carrier matrix, creating a standardized composite material that maintains the beneficial properties of both tissue types while ensuring manufacturing consistency
Data Source
AI summary
The invention relates generally to the fields of biology and life sciences. More particularly, the invention relates to compositions and methods for modulating cellular physiology and pathological processing using a combination of compounds that can be found in morselized amniotic membrane tissue and morselized umbilical cord tissue preparations.